| 标题 |
 IMbrave150: Exploratory analysis to examine the association between treatment response and overall survival (OS) in patients (pts) with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：Michel Ducreux; Andrew X. Zhu; Ann-Lii Cheng; Peter R. Galle; Masafumi Ikeda; et al 出版日期：2021-06-02 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
DW
老的火龙果
无极微光
秋风
xing_xing
Nole
OK
aajhajkahna
aaaa
cdercder
coolru
贪玩的秋柔
grassland
DOC_XIONG
Criminology34
Enigma_GEB
Lingeek
Ali
Kao
嘉心糖
皖公网安备34019202002308
